The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease
Ischemic heart disease (IHD) is the leading cause of mortality worldwide. Stem cell transplantation has become a promising approach for the treatment of IHD in recent decades. It is generally recognized that preclinical cell-based therapy is effective and have yielded encouraging results, which invo...
Main Authors: | Chuanbin Liu, Dong Han, Ping Liang, Yang Li, Feng Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.636136/full |
Similar Items
-
Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier
by: Merlin Sobia Poomani, et al.
Published: (2022-03-01) -
Modulation of Mesenchymal Stem Cells for Enhanced Therapeutic Utility in Ischemic Vascular Diseases
by: Sally L. Elshaer, et al.
Published: (2021-12-01) -
Regulation of Endothelial Progenitor Cell Functions in Ischemic Heart Disease: New Therapeutic Targets for Cardiac Remodeling and Repair
by: Huai Huang, et al.
Published: (2022-05-01) -
Evaluation of ischemic heart disease and viability by cardiac MRI
by: Mona Bhatia
Published: (2014-01-01) -
The prognostic role of high-sensitivity cardiac troponin T over time in ischemic and non-ischemic heart failure
by: Siyuan Li, et al.
Published: (2021-03-01)